Patent details

EP2311849 Title: Specific binding agents of human angiopoietin-2

Basic Information

Publication number:
EP2311849
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP100756436
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Specific binding agents of human angiopoietin-2
French Title of Invention:
Agent de liaison spécifique d'angiopoiétine 2
German Title of Invention:
Spezifische Bindungsmittel des menschlichen Angiopoietin-2
SPC Number:

Dates

Filing date:
11/10/2002
Grant date:
16/08/2017
EP Publication Date:
20/04/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/08/2017
EP B1 Publication Date:
16/08/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/10/2017
Expiration date:
11/10/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/08/2017
 
 

Name:
Amgen, Inc
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:
Oliner, Jonathan, Daniel
Address:
United States (US)

2

Name:
Min, Hosung
Address:
United States (US)

Priority

1

Priority Number:
328624 P
Priority Date:
11/10/2001
Priority Country:
United States (US)

2

Priority Number:
414155 P
Priority Date:
27/09/2002
Priority Country:
United States (US)

3

Priority Number:
269695
Priority Date:
10/10/2002
Priority Country:
United States (US)

Classification

IPC classification:
C07K 1/00; C07K 5/00; C07K 14/00;

Publication

European Patent Bulletin

Issue number:
201733
Publication date:
16/08/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2018 Outgoing Correspondence 1